Investor feedback for Phoenix’s seven year bond in 4% area
Phoenix Pharma is targeting a €250m-€300m bond issue after having finished its investor meetings today. A seven year bond could be sold as early as tomorrow.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
